NVS
NYSE · Healthcare
Novartis AG
$145.82
+1.20 (+0.83%)
Financial Highlights (FY 2026)
Revenue
40.30B
Net Income
10.00B
Gross Margin
75.8%
Profit Margin
24.8%
Rev Growth
+9.1%
D/E Ratio
0.77
Revenue & Net Income
Margin Trends
| FY 2026 | FY 2025 | |
|---|---|---|
| Gross Margin | 75.8% | 75.8% |
| Operating Margin | 31.0% | 27.9% |
| Profit Margin | 24.8% | 23.6% |
Income Statement
| FY 2026 | FY 2025 | |
|---|---|---|
| Revenue | 40.30B | 36.94B |
| Gross Profit | 30.55B | 28.01B |
| Operating Income | 12.49B | 10.31B |
| Net Income | 10.00B | 8.25B |
| Gross Margin | 75.8% | 75.8% |
| Operating Margin | 31.0% | 27.9% |
| Profit Margin | 24.8% | 23.6% |
| Rev Growth | +9.1% | +9.1% |
Balance Sheet
| FY 2026 | FY 2025 | |
|---|---|---|
| Total Debt | 46.89B | 46.89B |
| Total Equity | 61.14B | 61.14B |
| D/E Ratio | 0.77 | 0.77 |
Cash Flow
| FY 2026 | FY 2025 | |
|---|---|---|
| EBITDA | 12.77B | 11.12B |
| Free Cash Flow | — | — |